---
title: Proteomics International Inks Israeli Distribution Deal for Diabetic Kidney Disease Immunoassay – 360Dx
description: “We believe entering both the European and Middle Eastern markets in recent weeks will drive demand for PromarkerD in 2021 and beyond,” said Richard Lipscombe, managing director of Perth, Australia-based Proteomics International, in a statement.
---

[News & Media ](https://www.proteomics.com.au/news-media)

# [Proteomics International Inks Israeli Distribution Deal for Diabetic Kidney Disease Immunoassay – 360Dx](https://www.proteomics.com.au/news-media/proteomics-international-inks-israeli-distribution-deal-for-diabetic-kidney-disease-immunoassay-360dx)

 Written by [Proteomics](https://www.proteomics.com.au/news-media/author/proteomics) | Nov 11, 2020 4:00:00 PM

“*We believe entering both the European and Middle Eastern markets in recent weeks will drive demand for PromarkerD in 2021 and beyond,” said Richard Lipscombe, managing director of Perth, Australia-based Proteomics International, in a statement.*

Article: [Proteomics International Inks Israeli Distribution Deal for Diabetic Kidney Disease Immunoassay](https://www.360dx.com/business-news/proteomics-international-inks-israeli-distribution-deal-diabetic-kidney-disease#.X7Ix9GgzaUk)

[View full post](https://www.proteomics.com.au/news-media/proteomics-international-inks-israeli-distribution-deal-for-diabetic-kidney-disease-immunoassay-360dx)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Proteomics"
  },
  "dateModified" : "2025-08-08T11:19:49.173Z",
  "datePublished" : "2020-11-11T16:00:00Z",
  "headline" : "Proteomics International Inks Israeli Distribution Deal for Diabetic Kidney Disease Immunoassay – 360Dx",
  "image" : {
    "@type" : "ImageObject",
    "height" : 60,
    "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
    "width" : 60
  },
  "mainEntityOfPage" : "https://www.proteomics.com.au/news-media/proteomics-international-inks-israeli-distribution-deal-for-diabetic-kidney-disease-immunoassay-360dx",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News & Media"
  }
}
```